Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.

about

Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q55114463

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Daptomycin versus placebo as a ...... a randomized controlled trial.

@en

Daptomycin versus placebo as a ...... a randomized controlled trial.

@nl

type

Item

label

Daptomycin versus placebo as a ...... a randomized controlled trial.

@en

Daptomycin versus placebo as a ...... a randomized controlled trial.

@nl

prefLabel

Daptomycin versus placebo as a ...... a randomized controlled trial.

@en

Daptomycin versus placebo as a ...... a randomized controlled trial.

@nl

P1476

Daptomycin versus placebo as a ...... a randomized controlled trial

@en

P2093

Guillaume Butler-Laporte

http://www.w3.org/2001/XMLSchema#string

Katryn Paquette

http://www.w3.org/2001/XMLSchema#string

Todd C Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

Guidelines for the management of intravascular catheter-related infections.

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study

Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.

β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

P2888

s13063-018-2668-6

P304

297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13063-018-2668-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew P. Cheng

Alexander Lawandi

P577

2018-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104293459

http://www.w3.org/2001/XMLSchema#string

P698

29843781

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

5975696

http://www.w3.org/2001/XMLSchema#string